Description:

E1105 Quality of Life Assessment Form First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17363D95-6129-3B27-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17363D95-6129-3B27-E044-0003BA3F9857

Keywords:

Clinical Trial

Quality of Life

Breast Neoplasms

Versions (3) ▾

4/19/12
12/22/14
1/9/15

Uploaded on:

January 9, 2015

DOI:

No DOI assigned. To request one please log in.

License:

Creative Commons BY-NC 3.0 Legacy

Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Quality of Life Assessment Form (E1105)

Details

INSTRUCTIONS: After patient is off treatment, complete this form for each required follow-up report period (see forms submission schedule).

StudyEvent: E1105 Quality of Life Assessment Form
1. INSTRUCTIONS: After patient is off treatment, complete this form for each required follow-up report period (see forms submission schedule).

Administrative documentation

ECOG Protocol Number

ECOG Patient ID

DCI Name

Registration Step

Patient Initials (Last, First)

ECOG Protocol Number

Participating Group Protocol Number

Institution/Affiliate